APYX vs. GROY
APYX (Apyx Medical Corporation) and GROY (Gold Royalty Corp.) are both stocks. APYX operates in Medical Devices (Healthcare), while GROY operates in Other Precious Metals & Mining (Basic Materials). Over the past 5 years, APYX returned -14.55%/yr vs -11.34%/yr for GROY. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
APYX vs. GROY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, APYX achieves a 17.14% return, which is significantly higher than GROY's -35.64% return.
APYX
- 1D
- -0.49%
- 1M
- -4.65%
- 6M
- 1.99%
- YTD
- 17.14%
- 1Y
- 134.29%
- 3Y*
- -9.49%
- 5Y*
- -14.55%
- 10Y*
- —
- ALL TIME*
- -8.39%
GROY
- 1D
- -3.35%
- 1M
- -9.09%
- 6M
- -39.25%
- YTD
- -35.64%
- 1Y
- -2.99%
- 3Y*
- 14.33%
- 5Y*
- -11.34%
- 10Y*
- —
- ALL TIME*
- -9.27%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $248.17K | $250.43K | $617.49K | |
| $5.32M | $4.90M | $5.56M |
APYX vs. GROY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 17.14% | 121.52% | -39.69% | 11.97% | -81.75% | 19.37% |
GROY Gold Royalty Corp. | -35.64% | 233.88% | -17.69% | -36.27% | -51.98% | 9.33% |
Correlation
The correlation between APYX and GROY is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2021 | 0.12 |
Fundamentals
APYX:
$172.65M
GROY:
$491.25M
APYX:
-$0.33
GROY:
-$0.01
APYX:
2.03
GROY:
28.07
APYX:
$55.83M
GROY:
$19.65M
APYX:
$21.29M
GROY:
$14.42M
APYX:
-$3.18M
GROY:
$9.22M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
APYX vs. GROY — Risk / Return Rank
APYX
GROY
APYX vs. GROY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Gold Royalty Corp. (GROY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| APYX | GROY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.42 | ||
| Sortino ratioReturn per unit of downside risk | +2.00 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.05 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 3.15 | 0.02 | +3.13 |
| Martin ratioReturn relative to average drawdown | 8.56 | 0.05 | +8.51 |
Loading charts...
Drawdowns
APYX vs. GROY - Drawdown Comparison
The maximum APYX drawdown since its inception was -94.99%, which is greater than GROY's maximum drawdown of -82.01%. Use the drawdown chart below to compare losses from any high point for APYX and GROY.
Loading charts...
Drawdown Indicators
| APYX | GROY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.99% | -82.01% | -12.98% |
Max Drawdown (1Y)Largest decline over 1 year | -36.59% | -51.63% | +15.04% |
Max Drawdown (3Y)Largest decline over 3 years | -82.74% | -51.63% | -31.11% |
Max Drawdown (5Y)Largest decline over 5 years | -94.99% | -78.45% | -16.54% |
Current DrawdownCurrent decline from peak | -76.44% | -60.02% | -16.42% |
Average DrawdownAverage peak-to-trough decline | -57.33% | -55.87% | -1.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.46% | 26.02% | -12.56% |
Volatility
APYX vs. GROY - Volatility Comparison
Apyx Medical Corporation (APYX) has a higher volatility of 17.96% compared to Gold Royalty Corp. (GROY) at 11.00%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than GROY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| APYX | GROY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.96% | 11.00% | +6.96% |
Volatility (6M)Calculated over the trailing 6-month period | 55.31% | 37.11% | +18.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.07% | 55.46% | +24.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 100.64% | 56.52% | +44.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 92.69% | 59.86% | +32.83% |
Dividends
APYX vs. GROY - Dividend Comparison
Neither APYX nor GROY has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GROY Gold Royalty Corp. | 0.00% | 0.00% | 0.00% | 1.36% | 1.72% |
Financials
APYX vs. GROY - Financials Comparison
This section allows you to compare key financial metrics between Apyx Medical Corporation and Gold Royalty Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
APYX vs. GROY - Profitability Comparison
APYX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported a gross profit of 7.93M and revenue of 12.42M. Therefore, the gross margin over that period was 63.8%.
GROY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Gold Royalty Corp. reported a gross profit of 5.48M and revenue of 7.18M. Therefore, the gross margin over that period was 76.3%.
APYX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported an operating income of -911.00K and revenue of 12.42M, resulting in an operating margin of -7.3%.
GROY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Gold Royalty Corp. reported an operating income of 2.64M and revenue of 7.18M, resulting in an operating margin of 36.7%.
APYX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported a net income of -2.11M and revenue of 12.42M, resulting in a net margin of -17.0%.
GROY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Gold Royalty Corp. reported a net income of 1.77M and revenue of 7.18M, resulting in a net margin of 24.7%.
Frequently Asked Questions
APYX and GROY have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
APYX has higher volatility (17.96%) compared to GROY (11.00%). In terms of maximum drawdown, APYX dropped -94.99% vs GROY's -82.01%.
APYX currently has the higher Sharpe Ratio (1.44 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for APYX and GROY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer